SA analyst downgrades: PLTR, PSTG, NTLA, ARWR

Here are the latest stock rating downgrades by Seeking Alpha analysts:

Palantir (NASDAQ:PLTR). Hold to sell by Bay Area Ideas. “Despite strong fundamentals, Palantir’s P/S ratio is extremely elevated, trading at a massive premium to the sector and disconnected from growth rates. Given overvaluation and receding technical strength, I downgrade Palantir to a sell, as risk of a significant down move now outweighs bullish factors.”

Pure Storage (NYSE:PSTG). Hold to sell by Gary Alexander. “At current valuations above 30x P/E, Pure Storage is too expensive given its operational challenges—I’m downgrading to sell and recommend locking in gains.”

Intellia Therapeutics (NASDAQ:NTLA). Buy to hold by Edmund Ingham. “Given the unresolved safety questions and high cash burn, I remain on the sidelines, seeing both high risk and high reward potential for NTLA stock.”

Arrowhead Pharmaceuticals (NASDAQ:ARWR). Hold to sell by Edmund Ingham. “Arrowhead lacks a standout candidate for me and is subject to significant competitive threats, leading to my rating downgrade for ARWR stock.”